RPG Life Sciences Limited (NSE:RPGLIFE)

RPG Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 24, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	38,592	25,279	11,585	9,269	6,407	2,808
Market Cap Growth	63.52%	118.21%	24.98%	44.67%	128.15%	-31.49%
Enterprise Value	37,333	24,260	10,780	8,672	6,386	2,913
Last Close Price	2333.40	1513.25	685.14	539.08	367.70	161.16
PE Ratio	48.77	28.84	17.13	18.01	16.02	9.68
PS Ratio	6.06	4.34	2.26	2.11	1.65	0.75
PB Ratio	10.17	6.74	3.77	3.62	2.96	1.59
P/TBV Ratio	10.91	7.29	4.22	4.19	3.57	2.09
P/FCF Ratio	-	100.59	19.94	22.72	12.88	7.12
P/OCF Ratio	-	26.79	12.76	14.32	11.00	5.60
EV/Sales Ratio	5.86	4.17	2.10	1.97	1.64	0.78
EV/EBITDA Ratio	24.54	19.08	10.53	10.25	9.34	5.17
EV/EBIT Ratio	27.79	21.84	12.24	12.26	11.90	6.78
EV/FCF Ratio	-	96.54	18.56	21.26	12.83	7.39
Debt / Equity Ratio	-	-	0	0.00	0.01	0.07
Debt / EBITDA Ratio	-	-	0.00	0.01	0.03	0.20
Debt / FCF Ratio	-	-	0	0.02	0.04	0.30
Asset Turnover	-	1.25	1.34	1.36	1.37	1.45
Inventory Turnover	-	1.93	1.98	2.08	2.58	3.01
Quick Ratio	-	1.35	1.50	1.34	1.28	0.82
Current Ratio	-	2.28	2.57	2.58	2.21	1.52
Return on Equity (ROE)	-	25.69%	24.01%	21.80%	20.36%	17.21%
Return on Assets (ROA)	-	14.89%	14.41%	13.65%	11.77%	10.37%
Return on Capital (ROIC)	23.48%	20.35%	19.52%	18.61%	16.49%	13.93%
Return on Capital Employed (ROCE)	-	29.10%	27.80%	26.70%	24.00%	23.30%
Earnings Yield	2.05%	3.47%	5.84%	5.55%	6.24%	10.33%
FCF Yield	-	0.99%	5.01%	4.40%	7.77%	14.04%
Dividend Yield	0.69%	1.06%	1.75%	1.78%	1.96%	2.48%
Payout Ratio	-	22.64%	23.48%	23.14%	-	36.50%
Buyback Yield / Dilution	-0.01%	-	-	-	-	-
Total Shareholder Return	0.68%	1.06%	1.75%	1.78%	1.96%	2.48%

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.